SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-027307
Filing Date
2020-05-28
Accepted
2020-05-28 16:05:59
Documents
50
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gern-10q_20200331.htm 10-Q 1821813
2 EX-10.1 gern-ex101_7.htm EX-10.1 71307
3 EX-31.1 gern-ex311_10.htm EX-31.1 17405
4 EX-31.2 gern-ex312_6.htm EX-31.2 17417
5 EX-32.1 gern-ex321_8.htm EX-32.1 7631
6 EX-32.2 gern-ex322_9.htm EX-32.2 7613
  Complete submission text file 0001564590-20-027307.txt   5973547

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT gern-20200331.xml EX-101.INS 1353297
8 XBRL TAXONOMY EXTENSION SCHEMA gern-20200331.xsd EX-101.SCH 32761
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gern-20200331_cal.xml EX-101.CAL 42639
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gern-20200331_def.xml EX-101.DEF 108032
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE gern-20200331_lab.xml EX-101.LAB 292952
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gern-20200331_pre.xml EX-101.PRE 204395
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20859 | Film No.: 20921083
SIC: 2834 Pharmaceutical Preparations